Sterimed has restructured its capital, gaining independence and investor support to target €600 million in revenue by 2030.

Information on the Target

The Sterimed Group, a prominent French company, is a global leader in medical packaging. Recently, Sterimed has finalized an agreement to restructure its capital, allowing its management team to gain independence and implement a new ambitious strategic plan. This restructuring will enable Sterimed to aim for a revenue target of €600 million by 2030, bolstered by the support of IK Partners, Sagard, and a group of investors named 'Les Amis de Sterimed.'

Following the agreement, the management, led by Thibaut Hyvernat, now holds approximately 42% of Sterimed's equity. The renewed commitment from investors, including a significant increase in investment from Sagard, ensures enhanced financial resources and the continuation of its growth strategy in both existing and new markets.

Industry Overview in France

The medical packaging industry in France is characterized by its innovation and strong growth potential, driven by increasing healthcare demands and stringent regulatory sta